Navigation Links
BioNano Genomics Announces The Purchase Of The Irys System By The Wellcome Trust Sanger Institute
Date:8/12/2014

SAN DIEGO, Aug. 12, 2014 /PRNewswire/ -- BioNano Genomics announced today the purchase of an IrysTM System by the Wellcome Trust Sanger Institute, one of the world's leading genome centers, located near Cambridge, UK.  The Sanger Institute made the largest single contribution to the gold standard sequence for the Human Genome Project and today is focused on the role of genetics in health and disease. The Sanger Institute purchased BioNano's Irys platform to detect structural variation and complete genomes for various projects including the Cancer Genomics Project, which seeks to develop new ways of detecting rearrangements in cancer samples, and the Parasite Genomics Team, which is sequencing the genomes of parasites that cause malaria and neglected tropical diseases prevalent in the developing world.

"Cancer is the most common genetic disease. One in three people in the Western world develops cancer, and one in five will die of the disease," said Peter Campbell, Ph.D., head of Cancer Genetics and Genomics and joint head of the Cancer Genome Project at the Sanger Institute. "To understand the diseases of cancer fully, we need to develop new ways of detecting rearrangements in cancer samples, so we can begin to understand how our knowledge of abnormalities in the DNA sequence can help to personalize treatment and understand risk."

Genome maps built with the Irys System not only reveal the biologically and clinically significant order and orientation of functionally relevant components of complex genomes such as genes, promoters, and regulatory elements, but also identify the length and location of long areas of repeats as well as virus components integration sites across the entire genome. Assembling such a comprehensive view of a genome has previously been a major hurdle because information about repetitive elements and structural variations are lost with next generation sequencing (NGS) methods.

"We are seeking to streamline the way in which we produce complete genome sequences for parasites," said Matt Berriman, group leader of the Parasite Genomics Team at the Sanger Institute. "The biology of parasites is often unusual and by completing these genomes, they will become much easier to mine for new insights that could eventually lead to the development of new and specific medicines to help eradicate the parasites and the diseases they cause."

While the price to generate short read sequences has decreased, one major bottleneck has been in the labor-intensive approaches to genome assembly, annotation, and structural variation analysis.  BioNano's Irys System streamlines the process by providing a high-quality genome map, upon which DNA sequences can quickly and accurately be organized, and provides a single platform to perform large, comprehensive structural variation studies.

"In these projects with the Sanger Institute on parasite and cancer genomics, we hope to develop new, innovative approaches to improve genome finishing projects as well as identify novel rearrangements underlying disease mechanisms," said Fahim Amini, Ph.D. vice president, Commercial Operations EMEA. "Working closely with Sanger Institute's world leading research teams will also advance our development of future products and tools specifically for clinical applications."

About The Wellcome Trust Sanger Institute

The Wellcome Trust Sanger Institute is one of the world's leading genome centres. Through its ability to conduct research at scale, it is able to engage in bold and long-term exploratory projects that are designed to influence and empower medical science globally. Institute research findings, generated through its own research programmes and through its leading role in international consortia, are being used to develop new diagnostics and treatments for human disease. The Wellcome Trust Sanger Institute does not endorse commercial products. For more information, visit www.sanger.ac.uk/

About Irys

Irys makes it possible to routinely and accurately detect genomic structural variation and to finish genome assemblies. The fully automated Irys benchtop instrument uses the IrysChip to uncoil and confine long DNA molecules in proprietary Nanochannel Arrays™ where they are uniformly linearized in a highly parallel display for high-resolution, single-molecule imaging. Irys does not employ DNA fragmentation or amplification, which are typical with next-generation sequencing. The result is sequence information over extremely long "reads" ranging from hundreds of kilobases to a megabase, where the sample's valuable structural information is preserved. Irys makes it possible for researchers to directly observe structural variants including replications, deletions, translocations and inversions.

About BioNano Genomics

Headquartered in San Diego, BioNano Genomics is delivering an altogether better way of gaining a fully informed understanding of genomes. The Company's platform provides researchers and clinicians the most comprehensive, organized and actionable picture of a genome with unprecedented insights into how the individual components of genomes are ordered, arranged, and interact with each other. BioNano Genomics works with institutions in life science, translational research, molecular diagnostics and personalized medicine. The Company is supported by private investors and grant funding from genomics programs at federal agencies, including the NIH and NIST-ATP.

www.BioNanoGenomics.com

Notes: BioNano Genomics is a trademark of BioNano Genomics, Inc. Any other names of actual companies, organizations, entities, products or services may be the trademarks of their respective owners.


'/>"/>
SOURCE BioNano Genomics
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. BioNano Genomics Launches Irys In Europe At ESHG 2013
2. BioNano Genomics führt auf ESHG 2013 Irys in Europa ein
3. BioNano Genomics lanza Irys en Europa en ESHG 2013
4. BIT Group Partners with BioNano Genomics to Produce Revolutionary Genomics Platform
5. BioNano Genomics Announces The Purchase Of The Irys System By The Chinese Academy Of Sciences And Tel Aviv University
6. BioNano Genomics Announces the Adoption of Irys System by the Garvan Institute of Medical Research
7. BioNano Genomics Signs Two New Distributors For The Asia-Pacific Region And Announces First Irys System Placement In Korea To ChunLab
8. BioNano Genomics Announces the Purchase of the Irys System by BGI
9. Synthetic Genomics Inc. Hires Industry Leader George E. Stagnitti to Head Food and Nutritional Products Development Program
10. New England Biolabs Signs Agreement with Synthetic Genomics Inc. to Launch Gibson Assembly™ Master Mix for Molecular and Synthetic Biology Applications
11. Rubicon Genomics and Agendia Sign Agreement for Use of TransPLEX® Whole Genome RNA Amplification Technology With Symphony™ Cancer Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/3/2018)... ... , ... Milwaukee Area Technical College (MATC), a public, two-year comprehensive technical college, ... Room T129 in the T Building, 101 N. 6th St., to introduce area students, ... and formal program will be held at 4 p.m. , MATC recently added new ...
(Date:10/2/2018)... ... October 02, 2018 , ... Finalists for the 2018 ... AssurEOR product line was chosen for its advancements in the production chemicals category. ... innovations in upstream oil applications that are positively impacting the industry. The winners ...
(Date:10/2/2018)... ... October 02, 2018 , ... ... week that teams have initiated validation of standards and testing of procedures for ... of Dr. Larry Kennedy, ACRES VP for Quality Management Systems and Chief Quality ...
(Date:9/28/2018)... ... September 28, 2018 , ... ... increase the availability of the GlycoMark test, the only FDA-cleared blood test specific ... partnership, PMLS will promote and offer the GlycoMark test to its network of ...
Breaking Biology Technology:
(Date:10/16/2018)... ... October 15, 2018 , ... Modality ... highly regulated industries, is a silver sponsor and exhibitor at the Executive Platforms’ ... , The Biomanufacturing World Summit brings together the “who’s who” of pharmaceutical executives, ...
(Date:10/13/2018)... , ... October 12, 2018 , ... ... Medwell, MD, board certified in colorectal surgery, to its Medical Advisory Board. Joining ... will bring to uBiome his deep expertise in the surgical treatments of ulcerative ...
(Date:10/11/2018)... ... October 09, 2018 , ... ... identifies, counsels, and supports high-growth, high-impact life science and biotechnology companies, announced ... national nonprofit disease foundations to discuss their investment philosophies, explain their fund ...
Breaking Biology News(10 mins):